Progerinin

DRUG3 trials

Sponsors

PRG Science & Technology Co., Ltd.

Conditions

Hutchinson-Gilford Progeria SyndromeWerner Syndrome

Phase 1

Phase I Study of Progerinin in Healthy Volunteers

CompletedNCT04512963

PRG Science & Technology Co., Ltd.Hutchinson-Gilford Progeria Syndrome, Werner Syndrome

Start: 2020-08-24End: 2021-07-27Updated: 2021-09-22

Phase 2

Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome

Not yet recruitingNCT05847179

PRG Science & Technology Co., Ltd.Werner Syndrome

Start: 2026-07-01End: 2027-12-01Target: 5Updated: 2026-01-23

Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients With Hutchinson-Gilford Progeria Syndrome (HGPS)

Active, not recruitingNCT06775041

PRG Science & Technology Co., Ltd.Hutchinson-Gilford Progeria Syndrome

Start: 2025-01-13End: 2026-03-01Updated: 2026-02-09